Shenzhen YHLO Biotech Co., Ltd. (688575.SS)

23.98 +0.03 (+0.13%) At close: 03:00PM CST

Shenzhen YHLO Biotech Co., Ltd.

Building 1, Baolong, 2nd Road
Yahuilong Biotechnology Factory Baolong Street Longgang District
Shenzhen 518116
China
86 755 2647 3359
https://www.szyhlo.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 1,759

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Kunhui Hu	Chairman of the Board & Acting Board Secretary	N/A	N/A	1991
Mr. Yongbo Song	GM & Vice Chairman of the Board	N/A	N/A	1984
Mr. Yujing Xiao	Deputy General Manager	N/A	N/A	1976

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. The company offers automatic chemiluminescence immunoassay analyzers, chemiluminescent immunoassay analyzers, and iModule automatic immunoassay pipelines; and automatic immunofluorescence staining systems, automatic immunofluorescence analysis systems, automatic western blotting analyzers, auto automatic western blot analyzers, and automatic western blotting instruments. It also provides UNION new generation immune analyzers; dry fluorescence immunoassay analyzers, vision automatic dynamic ESR analyzers, and vision dynamic ESR analyzers; and automated sample processing systems and intelligent laboratory information systems, as well as antigen detection and test kits. Shenzhen YHLO Biotech Co., Ltd. was founded in 2008 and is headquartered in Shenzhen, China.

Corporate governance

Shenzhen YHLO Biotech Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.